Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/18/1996 | EP0748317A1 Novel thiazolidin-4-one derivatives |
12/18/1996 | EP0748312A1 Bicyclic carbamates as leukotriene d4 antagonists |
12/18/1996 | EP0748228A1 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
12/18/1996 | EP0748225A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
12/18/1996 | EP0748222A1 Antitussive composition containing an antitussive and benzydamine |
12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
12/18/1996 | EP0690855B1 Benzopyranes as potassium channel openers |
12/18/1996 | EP0666736B1 Stabilization of fluorocarbon emulsions |
12/17/1996 | US5585400 Administering conjugated linoleic acid |
12/17/1996 | US5585372 Tricyclic cefem sulphones |
12/17/1996 | CA2111461C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
12/12/1996 | WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES |
12/12/1996 | WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
12/12/1996 | WO1996039383A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
12/12/1996 | WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
12/12/1996 | WO1996011949A3 Analogs of keratinocyte growth factor |
12/12/1996 | CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
12/12/1996 | CA2223239A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
12/11/1996 | EP0747363A1 Anti-viral benzimidazole derivatives |
12/11/1996 | EP0747354A1 3-Substituted oxindole derivatives as potassium channel modulators |
12/11/1996 | EP0747353A2 Indole derivatives |
12/11/1996 | EP0747347A1 RARy-specific retinobenzoic acid derivatives |
12/11/1996 | EP0746619A1 Human phosphodiesterase type ivc, and its production and use |
12/11/1996 | EP0746557A1 Intracellular signalling mediators |
12/11/1996 | CN1137794A 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists |
12/11/1996 | CN1137793A 6-(2-imidzolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
12/11/1996 | CN1137755A 6-(2-imidazolinylamino) quinoxaling compounds useful as alpha-2 adrenoceptor agonists |
12/11/1996 | CN1137754A 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists |
12/11/1996 | CN1137398A Chinese medicine composite for curing bronchial disease |
12/10/1996 | US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives |
12/10/1996 | US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents |
12/10/1996 | US5583117 Acylated uridine and cytidine for elevating tissue uridine and cytidine |
12/07/1996 | CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives |
12/05/1996 | WO1996038559A1 Chemokine n-terminal deletion mutations |
12/05/1996 | WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/05/1996 | WO1996038436A1 (2-thienyl)alkanoic acid derivatives |
12/05/1996 | WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
12/05/1996 | WO1996038172A1 Connective tissue growth factor |
12/05/1996 | WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent |
12/05/1996 | WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
12/05/1996 | CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/05/1996 | CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent |
12/05/1996 | CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
12/05/1996 | CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
12/04/1996 | EP0745063A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors |
12/04/1996 | EP0744950A1 Agent for prophylaxis and treatment of thromboxane a 2?-mediated diseases |
12/04/1996 | CN1137270A Novel imidazole derivative and process for producing the same |
12/04/1996 | CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
12/04/1996 | CN1136956A Compound pill of trachitis |
12/04/1996 | CN1136951A Granule for clearing away heat and toxic material and hemostasis |
12/04/1996 | CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions |
12/03/1996 | US5581011 Antihistamine intermediates |
12/03/1996 | US5580888 Administering for therapy and prophylaxis of asthma; potent phosphodiesterase iv isoenzyme inhibitors |
12/03/1996 | US5580869 1N substituted pyrazino[2,3-c]-1,2,6-thiadiazine 2,2-dioxides |
12/03/1996 | US5580865 2,2-disubstituted cephem sulphones |
12/03/1996 | US5580558 Delivery of gene products via mesangial cells |
11/28/1996 | WO1996037490A1 Benzopyrans and pharmaceutical compositions containing them |
11/28/1996 | WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists |
11/28/1996 | WO1996037488A1 Piperazine derivatives |
11/28/1996 | CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists |
11/27/1996 | EP0743953A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
11/27/1996 | EP0743944A1 Azacyclic derivatives |
11/27/1996 | EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
11/26/1996 | US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors |
11/26/1996 | US5578631 Methods of combating Pneumocystis carinii pneumonia and compounds useful therefor |
11/26/1996 | US5578612 Indole derivatives |
11/26/1996 | US5578610 Piperidine derivatives |
11/26/1996 | CA2078287C Nitroxides as protectors against oxidative stress |
11/26/1996 | CA1338736C Microcrystals containing an active ingredient with affinity for phospholipids and at least one phospholipid; process for preparing the same |
11/21/1996 | WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
11/21/1996 | WO1996036638A1 Xanthines and their therapeutic use |
11/21/1996 | WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
11/21/1996 | WO1996036324A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions |
11/21/1996 | WO1996030042A3 Methods of treating inflammation and compositions therefor |
11/21/1996 | CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
11/21/1996 | CA2220687A1 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions |
11/21/1996 | CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
11/21/1996 | CA2218548A1 Xanthines and their therapeutic use |
11/20/1996 | CN1136314A Isoxazoline compounds as antiinflammatory agents |
11/20/1996 | CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
11/19/1996 | US5576438 Lipoxygenase inhibitors; antiallergens, antiinflammatory agents |
11/19/1996 | US5576437 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
11/19/1996 | US5576333 Asthma treatment |
11/19/1996 | US5576322 Anti-ischemic 2,4-diaminoquinazolines |
11/14/1996 | WO1996035671A1 β-ADRENERGIC AGONISTS |
11/14/1996 | WO1996035670A1 β-ADRENERGIC AGONISTS |
11/14/1996 | WO1996031186A3 Product and method for preventing respiratory virus infection |
11/14/1996 | CA2220538A1 .beta.-adrenergic agonists |
11/14/1996 | CA2220399A1 .beta.-adrenergic agonists |
11/13/1996 | EP0741743A1 Cyclic neurokinin a antagonists |
11/13/1996 | EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
11/13/1996 | EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
11/13/1996 | EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents |
11/13/1996 | EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
11/13/1996 | EP0741577A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections |
11/13/1996 | EP0741571A1 Use of 2- 4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
11/12/1996 | CA2040319C Sulfonylamino substituted bicyclyl hydroxamic acid derivatives |
11/12/1996 | CA2012295C Pyrrolidine derivatives |
11/07/1996 | WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
11/07/1996 | WO1996034864A1 Piperazino derivatives as neurokinin antagonists |